Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Tye MA"'
Autor:
Winser John Stanley, Chan Kit Laam Kelly, Chinn Ching Tung, Tang Wai Lok, Tye Man Kit Ringo, Yeung Kai Ho, Raymond Cheung
Publikováno v:
Frontiers in Neurology, Vol 11 (2020)
Background: Cerebellar ataxia affects the coordination and balance of patients. The impact of this disease increases burden in patients, caregivers and society. Costs and the burden of this disease have not been investigated in Hong Kong.Objectives:
Externí odkaz:
https://doaj.org/article/de8887bb221449a584fce24ebc171355
Autor:
Mandt REK; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, United States., Luth MR; Division of Host Pathogen Systems and Therapeutics, Department of Pediatrics, University of California, San Diego, San Diego, United States., Tye MA; Center for Systems Biology, Massachusetts General Hospital, Boston, United States.; Harvard Graduate School of Arts and Sciences, Cambridge, United States., Mazitschek R; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, United States.; Center for Systems Biology, Massachusetts General Hospital, Boston, United States., Ottilie S; Division of Host Pathogen Systems and Therapeutics, Department of Pediatrics, University of California, San Diego, San Diego, United States., Winzeler EA; Division of Host Pathogen Systems and Therapeutics, Department of Pediatrics, University of California, San Diego, San Diego, United States.; Skaggs School of Pharmaceutical Sciences, University of California, San Diego, La Jolla, United States., Lafuente-Monasterio MJ; Tres Cantos Medicines Development Campus, Diseases of the Developing World, GlaxoSmithKline, Madrid, Spain., Gamo FJ; Tres Cantos Medicines Development Campus, Diseases of the Developing World, GlaxoSmithKline, Madrid, Spain., Wirth DF; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, United States.; Infectious Disease and Microbiome Program, The Broad Institute, Cambridge, United States., Lukens AK; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, United States.; Infectious Disease and Microbiome Program, The Broad Institute, Cambridge, United States.
Publikováno v:
ELife [Elife] 2023 Sep 22; Vol. 12. Date of Electronic Publication: 2023 Sep 22.
Autor:
Armstrong JF; Deanery of Biomedical Sciences, The University of Edinburgh, Edinburgh, UK., Campo B; Medicines for Malaria Venture, Geneva, Switzerland., Alexander SPH; School of Life Sciences, University of Nottingham Medical School, Nottingham, UK., Arendse LB; Drug Discovery and Development Centre (H3D), South African Medical Research Council Drug Discovery and Development Research Unit, Department of Chemistry, and Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa., Cheng X; Global Health Drug Discovery Institute, Beijing, China., Davenport AP; Experimental Medicine and Immunotherapeutics, University of Cambridge, Cambridge, UK., Faccenda E; Deanery of Biomedical Sciences, The University of Edinburgh, Edinburgh, UK., Fidock DA; Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, New York, USA.; Center for Malaria Therapeutics and Antimicrobial Resistance, Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, New York, USA., Godinez-Macias KP; Bioinformatics and Systems Biology Graduate Program, University of California, San Diego (UCSD), La Jolla, California, USA., Harding SD; Deanery of Biomedical Sciences, The University of Edinburgh, Edinburgh, UK., Kato N; Global Health Drug Discovery Institute, Beijing, China., Lee MCS; Parasites and Microbes Programme, Wellcome Sanger Institute, Hinxton, UK., Luth MR; Department of Pediatrics, University of California San Diego School of Medicine, La Jolla, California, USA., Mazitschek R; Center for Systems Biology, Massachusetts General Hospital, Boston, Massachusetts, USA., Mittal N; Thermo Fisher Scientific, San Diego, California, USA., Niles JC; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA., Okombo J; Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, New York, USA., Ottilie S; Department of Pediatrics, University of California San Diego School of Medicine, La Jolla, California, USA., Pasaje CFA; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA., Probst AS; Department of Immunology and Infectious Diseases, Harvard TH Chan School of Public Health, Boston, Massachusetts, USA., Rawat M; Parasites and Microbes Programme, Wellcome Sanger Institute, Hinxton, UK., Rocamora F; Department of Pediatrics, University of California San Diego School of Medicine, La Jolla, California, USA., Sakata-Kato T; Global Health Drug Discovery Institute, Beijing, China., Southan C; Deanery of Biomedical Sciences, The University of Edinburgh, Edinburgh, UK., Spedding M; Spedding Research Solutions SAS, Le Vésinet, France., Tye MA; Center for Systems Biology, Massachusetts General Hospital, Boston, Massachusetts, USA., Yang T; Department of Pediatrics, School of Medicine, University of California, San Diego, La Jolla, California, USA., Zhao N; Global Health Drug Discovery Institute, Beijing, China., Davies JA; Deanery of Biomedical Sciences, The University of Edinburgh, Edinburgh, UK.
Publikováno v:
British journal of pharmacology [Br J Pharmacol] 2023 Aug; Vol. 180 (15), pp. 1899-1929. Date of Electronic Publication: 2023 Jun 10.
Autor:
Kurata K; Jerome Lipper Multiple Myeloma Center, LeBow Institute for Myeloma Therapeutics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA., James-Bott A; Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, OX3 7LD, UK., Tye MA; Center for Systems Biology, Massachusetts General Hospital, Boston, MA, 02114, USA.; Harvard Graduate School of Arts and Sciences, Cambridge, MA, 02138, USA.; Harvard T.H. Chan School of Public Health, Boston, MA, 02115, USA., Yamamoto L; Jerome Lipper Multiple Myeloma Center, LeBow Institute for Myeloma Therapeutics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA., Samur MK; Jerome Lipper Multiple Myeloma Center, LeBow Institute for Myeloma Therapeutics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA.; Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA, 02115, USA.; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Tai YT; Jerome Lipper Multiple Myeloma Center, LeBow Institute for Myeloma Therapeutics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA., Dunford J; Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, OX3 7LD, UK., Johansson C; Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, OX3 7LD, UK., Senbabaoglu F; Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, OX3 7LD, UK., Philpott M; Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, OX3 7LD, UK., Palmer C; Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, OX3 7LD, UK., Ramasamy K; Oxford Centre for Translational Myeloma Research, Botnar Research Centre, University of Oxford, Oxford, OX3 7LD, UK.; Radcliffe Department of Medicine, University of Oxford, Oxford, OX3 7LD, UK., Gooding S; Oxford Centre for Translational Myeloma Research, Botnar Research Centre, University of Oxford, Oxford, OX3 7LD, UK.; Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, OX3 7LD, UK., Smilova M; Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, OX3 7LD, UK., Gaeta G; Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, OX3 7LD, UK., Guo M; Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, OX3 7LD, UK., Christianson JC; Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, OX3 7LD, UK.; Oxford Centre for Translational Myeloma Research, Botnar Research Centre, University of Oxford, Oxford, OX3 7LD, UK., Payne NC; Center for Systems Biology, Massachusetts General Hospital, Boston, MA, 02114, USA.; Department of Chemistry & Chemical Biology, Harvard University, Cambridge, MA, 02138, USA., Singh K; Center for Systems Biology, Massachusetts General Hospital, Boston, MA, 02114, USA.; Department of Bioengineering, Northeastern University, Boston, MA, 02115, USA., Karagoz K; Bristol Myers Squibb, Summit, NJ, 07901, USA., Stokes ME; Bristol Myers Squibb, Summit, NJ, 07901, USA., Ortiz M; Bristol Myers Squibb, Summit, NJ, 07901, USA., Hagner P; Bristol Myers Squibb, Summit, NJ, 07901, USA., Thakurta A; Oxford Centre for Translational Myeloma Research, Botnar Research Centre, University of Oxford, Oxford, OX3 7LD, UK.; Bristol Myers Squibb, Summit, NJ, 07901, USA., Cribbs A; Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, OX3 7LD, UK.; Oxford Centre for Translational Myeloma Research, Botnar Research Centre, University of Oxford, Oxford, OX3 7LD, UK., Mazitschek R; Center for Systems Biology, Massachusetts General Hospital, Boston, MA, 02114, USA.; Harvard T.H. Chan School of Public Health, Boston, MA, 02115, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA., Hideshima T; Jerome Lipper Multiple Myeloma Center, LeBow Institute for Myeloma Therapeutics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA. Teru_Hideshima@dfci.harvard.edu., Anderson KC; Jerome Lipper Multiple Myeloma Center, LeBow Institute for Myeloma Therapeutics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA. Kenneth_Anderson@dfci.harvard.edu., Oppermann U; Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, OX3 7LD, UK. Udo.Oppermann@ndorms.ox.ac.uk.; Oxford Centre for Translational Myeloma Research, Botnar Research Centre, University of Oxford, Oxford, OX3 7LD, UK. Udo.Oppermann@ndorms.ox.ac.uk.
Publikováno v:
Blood cancer journal [Blood Cancer J] 2023 Feb 07; Vol. 13 (1), pp. 24. Date of Electronic Publication: 2023 Feb 07.
Autor:
Kurata K; Jerome Lipper Multiple Myeloma Center, LeBow Institute for Myeloma Therapeutics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA., James-Bott A; Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, OX3 7LD, UK., Tye MA; Center for Systems Biology, Massachusetts General Hospital, Boston, MA, 02114, USA.; Harvard Graduate School of Arts and Sciences, Cambridge, MA, 02138, USA.; Harvard T.H. Chan School of Public Health, Boston, MA, 02115, USA., Yamamoto L; Jerome Lipper Multiple Myeloma Center, LeBow Institute for Myeloma Therapeutics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA., Samur MK; Jerome Lipper Multiple Myeloma Center, LeBow Institute for Myeloma Therapeutics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA.; Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA, 02115, USA.; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Tai YT; Jerome Lipper Multiple Myeloma Center, LeBow Institute for Myeloma Therapeutics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA., Dunford J; Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, OX3 7LD, UK., Johansson C; Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, OX3 7LD, UK., Senbabaoglu F; Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, OX3 7LD, UK., Philpott M; Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, OX3 7LD, UK., Palmer C; Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, OX3 7LD, UK., Ramasamy K; Oxford Centre for Translational Myeloma Research, Botnar Research Centre, University of Oxford, Oxford, OX3 7LD, UK.; Radcliffe Department of Medicine, University of Oxford, Oxford, OX3 7LD, UK., Gooding S; Oxford Centre for Translational Myeloma Research, Botnar Research Centre, University of Oxford, Oxford, OX3 7LD, UK.; Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, OX3 7LD, UK., Smilova M; Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, OX3 7LD, UK., Gaeta G; Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, OX3 7LD, UK., Guo M; Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, OX3 7LD, UK., Christianson JC; Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, OX3 7LD, UK.; Oxford Centre for Translational Myeloma Research, Botnar Research Centre, University of Oxford, Oxford, OX3 7LD, UK., Payne NC; Center for Systems Biology, Massachusetts General Hospital, Boston, MA, 02114, USA.; Department of Chemistry & Chemical Biology, Harvard University, Cambridge, MA, 02138, USA., Singh K; Center for Systems Biology, Massachusetts General Hospital, Boston, MA, 02114, USA.; Department of Bioengineering, Northeastern University, Boston, MA, 02115, USA., Karagoz K; Bristol Myers Squibb, Summit, NJ, 07901, USA., Stokes ME; Bristol Myers Squibb, Summit, NJ, 07901, USA., Ortiz M; Bristol Myers Squibb, Summit, NJ, 07901, USA., Hagner P; Bristol Myers Squibb, Summit, NJ, 07901, USA., Thakurta A; Oxford Centre for Translational Myeloma Research, Botnar Research Centre, University of Oxford, Oxford, OX3 7LD, UK.; Bristol Myers Squibb, Summit, NJ, 07901, USA., Cribbs A; Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, OX3 7LD, UK.; Oxford Centre for Translational Myeloma Research, Botnar Research Centre, University of Oxford, Oxford, OX3 7LD, UK., Mazitschek R; Center for Systems Biology, Massachusetts General Hospital, Boston, MA, 02114, USA.; Harvard T.H. Chan School of Public Health, Boston, MA, 02115, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA., Hideshima T; Jerome Lipper Multiple Myeloma Center, LeBow Institute for Myeloma Therapeutics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA. Teru_Hideshima@dfci.harvard.edu., Anderson KC; Jerome Lipper Multiple Myeloma Center, LeBow Institute for Myeloma Therapeutics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA. Kenneth_Anderson@dfci.harvard.edu., Oppermann U; Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, OX3 7LD, UK. Udo.Oppermann@ndorms.ox.ac.uk.; Oxford Centre for Translational Myeloma Research, Botnar Research Centre, University of Oxford, Oxford, OX3 7LD, UK. Udo.Oppermann@ndorms.ox.ac.uk.
Publikováno v:
Blood cancer journal [Blood Cancer J] 2023 Jan 12; Vol. 13 (1), pp. 12. Date of Electronic Publication: 2023 Jan 12.
Autor:
Tye MA; Center for Systems Biology, Massachusetts General Hospital, Boston, MA, USA.; Harvard Graduate School of Arts and Sciences, Cambridge, MA, USA.; Harvard T.H. Chan School of Public Health, Boston, MA, USA., Payne NC; Center for Systems Biology, Massachusetts General Hospital, Boston, MA, USA.; Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA, USA., Johansson C; Botnar Research Centre, NIHR Oxford Biomedical Research Unit, University of Oxford, Oxford, UK.; Centre for Medicines Discovery, University of Oxford, Oxford, UK., Singh K; Center for Systems Biology, Massachusetts General Hospital, Boston, MA, USA.; Department of Bioengineering, Northeastern University, Boston, MA, USA., Santos SA; Center for Systems Biology, Massachusetts General Hospital, Boston, MA, USA., Fagbami L; Center for Systems Biology, Massachusetts General Hospital, Boston, MA, USA.; Harvard Graduate School of Arts and Sciences, Cambridge, MA, USA.; Harvard T.H. Chan School of Public Health, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Pant A; Harvard T.H. Chan School of Public Health, Boston, MA, USA., Sylvester K; Department of Chemistry, Duke University, Durham, NC, USA., Luth MR; Department of Pediatrics, University of California, San Diego, La Jolla, CA, USA., Marques S; Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal., Whitman M; Department of Developmental Biology, Harvard School of Dental Medicine, Boston, MA, USA., Mota MM; Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal., Winzeler EA; Department of Pediatrics, University of California, San Diego, La Jolla, CA, USA., Lukens AK; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Derbyshire ER; Department of Chemistry, Duke University, Durham, NC, USA., Oppermann U; Botnar Research Centre, NIHR Oxford Biomedical Research Unit, University of Oxford, Oxford, UK.; Centre for Medicines Discovery, University of Oxford, Oxford, UK., Wirth DF; Harvard T.H. Chan School of Public Health, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Mazitschek R; Center for Systems Biology, Massachusetts General Hospital, Boston, MA, USA. ralph@broadinstitute.org.; Harvard T.H. Chan School of Public Health, Boston, MA, USA. ralph@broadinstitute.org.; Broad Institute of MIT and Harvard, Cambridge, MA, USA. ralph@broadinstitute.org.
Publikováno v:
Nature communications [Nat Commun] 2022 Aug 25; Vol. 13 (1), pp. 4976. Date of Electronic Publication: 2022 Aug 25.
Autor:
Payne NC; Center for Systems Biology, Massachusetts General Hospital, Boston, MA, USA.; Department of Chemistry & Chemical Biology, Harvard University, Cambridge, MA, USA., Kalyakina AS; Center for Systems Biology, Massachusetts General Hospital, Boston, MA, USA.; Karlsruhe Institute of Technology, Institute of Organic Chemistry, Karlsruhe, Germany., Singh K; Center for Systems Biology, Massachusetts General Hospital, Boston, MA, USA.; Department of Bioengineering, Northeastern University, Boston, MA, USA., Tye MA; Center for Systems Biology, Massachusetts General Hospital, Boston, MA, USA.; Harvard Graduate School of Arts and Sciences, Cambridge, MA, USA., Mazitschek R; Center for Systems Biology, Massachusetts General Hospital, Boston, MA, USA. ralph@broad.harvard.edu.; Harvard T.H. Chan School of Public Health, Boston, MA, USA. ralph@broad.harvard.edu.; Broad Institute of MIT and Harvard, Cambridge, MA, USA. ralph@broad.harvard.edu.
Publikováno v:
Nature chemical biology [Nat Chem Biol] 2021 Nov; Vol. 17 (11), pp. 1168-1177. Date of Electronic Publication: 2021 Oct 21.
Autor:
Sandoval DR, Clausen TM, Nora C, Cribbs AP, Denardo A, Clark AE, Garretson AF, Coker JKC, Narayanan A, Majowicz SA, Philpott M, Johansson C, Dunford JE, Spliid CB, Golden GJ, Payne NC, Tye MA, Nowell CJ, Griffis ER, Piermatteo A, Grunddal KV, Alle T, Magida JA, Hauser BM, Feldman J, Caradonna TM, Pu Y, Yin X, McVicar RN, Kwong EM, Weiss RJ, Downes M, Tsimikas S, Smidt AG, Ballatore C, Zengler K, Evans RM, Chanda SK, Croker BA, Leibel SL, Jose J, Mazitschek R, Oppermann U, Esko JD, Carlin AF, Gordts PLSM
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2021 Mar 26. Date of Electronic Publication: 2021 Mar 26.
Autor:
Tyan K; Greater Boston Pandemic Fabrication Team (PanFab) c/o Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Levin A; Greater Boston Pandemic Fabrication Team (PanFab) c/o Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston, Massachusetts, USA.; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts, USA., Avalos-Pacheco A; Greater Boston Pandemic Fabrication Team (PanFab) c/o Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston, Massachusetts, USA.; Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston, Massachusetts, USA.; Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Plana D; Greater Boston Pandemic Fabrication Team (PanFab) c/o Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston, Massachusetts, USA.; Harvard-MIT Division of Health Sciences & Technology, Cambridge, Massachusetts, USA.; Harvard Ludwig Cancer Research Center and Department of Systems Biology, Harvard Medical School, Boston, Massachusetts, USA., Rand EA; Greater Boston Pandemic Fabrication Team (PanFab) c/o Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston, Massachusetts, USA.; Harvard University Department of Systems Biology, Cambridge, Massachusetts, USA., Yang H; Greater Boston Pandemic Fabrication Team (PanFab) c/o Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston, Massachusetts, USA.; Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston, Massachusetts, USA., Maliszewski LE; Greater Boston Pandemic Fabrication Team (PanFab) c/o Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston, Massachusetts, USA.; Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston, Massachusetts, USA.; Harvard Program in Therapeutic Science, Cambridge, Massachusetts, USA.; Laboratory of Systems Pharmacology, Department of Systems Biology, Harvard Medical School, Boston, Massachusetts, USA., Chylek LA; Greater Boston Pandemic Fabrication Team (PanFab) c/o Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston, Massachusetts, USA.; Laboratory of Systems Pharmacology, Department of Systems Biology, Harvard Medical School, Boston, Massachusetts, USA., Atta L; Greater Boston Pandemic Fabrication Team (PanFab) c/o Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston, Massachusetts, USA.; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Tye MA; Greater Boston Pandemic Fabrication Team (PanFab) c/o Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston, Massachusetts, USA.; Harvard University Graduate School of Arts and Sciences, Cambridge, Massachusetts, USA.; Massachusetts General Hospital Center for Systems Biology, Boston, Massachusetts, USA., Carmack MM; Greater Boston Pandemic Fabrication Team (PanFab) c/o Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston, Massachusetts, USA.; Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston, Massachusetts, USA.; Computational Health Informatics Program, Boston Children's Hospital, Boston, Massachusetts, USA., Oglesby NS; Greater Boston Pandemic Fabrication Team (PanFab) c/o Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston, Massachusetts, USA.; Harvard Program in Therapeutic Science, Cambridge, Massachusetts, USA., Burgin S; Greater Boston Pandemic Fabrication Team (PanFab) c/o Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.; Brigham and Women's Hospital, Boston, Massachusetts, USA., Yu SH; Greater Boston Pandemic Fabrication Team (PanFab) c/o Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston, Massachusetts, USA.; Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut, USA., LeBoeuf NR; Greater Boston Pandemic Fabrication Team (PanFab) c/o Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston, Massachusetts, USA.; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Kemp JM; Greater Boston Pandemic Fabrication Team (PanFab) c/o Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston, Massachusetts, USA.; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Publikováno v:
Open forum infectious diseases [Open Forum Infect Dis] 2020 Aug 31; Vol. 7 (9), pp. ofaa396. Date of Electronic Publication: 2020 Aug 31 (Print Publication: 2020).